Alfresa Holdings (TSE:2784) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Alfresa Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alfresa Holdings's Free Cash Flow for the three months ended in Dec. 2023 was 円0 Mil. Alfresa Holdings's Revenue for the three months ended in Dec. 2023 was 円751,947 Mil. Therefore, Alfresa Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Alfresa Holdings's current FCF Yield % is -2.77%.

The historical rank and industry rank for Alfresa Holdings's FCF Margin % or its related term are showing as below:

TSE:2784' s FCF Margin % Range Over the Past 10 Years
Min: -1.93 Med: 0.79 Max: 1.35
Current: -0.44

During the past 13 years, the highest FCF Margin % of Alfresa Holdings was 1.35%. The lowest was -1.93%. And the median was 0.79%.

TSE:2784's FCF Margin % is ranked worse than
67.35% of 98 companies
in the Medical Distribution industry
Industry Median: 0.815 vs TSE:2784: -0.44

Alfresa Holdings FCF Margin % Historical Data

The historical data trend for Alfresa Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings FCF Margin % Chart

Alfresa Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

1.26

0.49

-1.51

0.76

-0.46

Alfresa Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Alfresa Holdings's FCF Margin %

For the Medical Distribution subindustry, Alfresa Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alfresa Holdings's FCF Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's FCF Margin % falls into.

Alfresa Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alfresa Holdings's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-12379	/	2696069
	=	-0.46 %

Alfresa Holdings's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	751947
	=	0.00 %

Alfresa Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alfresa Holdings (TSE:2784) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (TSE:2784) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004

Website

http://www.alfresa.com

Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (TSE:2784) Headlines

No Headlines